Related references
Note: Only part of the references are listed.Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Kasthuri Kannan et al.
Oncotarget (2015)
Loss of DAXX and ATRX Are Associated With Chromosome Instability and Reduced Survival of Patients With Pancreatic Neuroendocrine Tumors
Ilaria Marinoni et al.
GASTROENTEROLOGY (2014)
Rare Germline Mutations Identified by Targeted Next-Generation Sequencing of Susceptibility Genes in Pheochromocytoma and Paraganglioma
Jenny Welander et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity
Patricia L. M. Dahia
NATURE REVIEWS CANCER (2014)
Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing
Lauren Fishbein et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
ATRX The case of a peculiar chromatin remodeler
Kajan Ratnakumar et al.
EPIGENETICS (2013)
Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing
Joakim Crona et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas
Malak Abedalthagafi et al.
MODERN PATHOLOGY (2013)
The genetic landscape of high-risk neuroblastoma
Trevor J. Pugh et al.
NATURE GENETICS (2013)
Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
Camilo Jimenez et al.
CURRENT ONCOLOGY REPORTS (2013)
Succinate Dehydrogenase Mutation Underlies Global Epigenomic Divergence in Gastrointestinal Stromal Tumor
J. Keith Killian et al.
CANCER DISCOVERY (2013)
Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets
Robert Daber et al.
CANCER GENETICS (2013)
ATRX-mediated chromatin association of histone variant macroH2A1 regulates α-globin expression
Kajan Ratnakumar et al.
GENES & DEVELOPMENT (2012)
Integrative genomics reveals frequent somatic NF1 mutations in sporadic pheochromocytomas
Jenny Welander et al.
HUMAN MOLECULAR GENETICS (2012)
Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2012)
Association of Age at Diagnosis and Genetic Mutations in Patients With Neuroblastoma
Nai-Kong V. Cheung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
wANNOVAR: annotating genetic variants for personal genomes via the web
Xiao Chang et al.
JOURNAL OF MEDICAL GENETICS (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background
Lauren Fishbein et al.
CANCER GENETICS (2012)
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Yuchen Jiao et al.
ONCOTARGET (2012)
Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway
Courtney A. Lovejoy et al.
PLOS GENETICS (2012)
Updated and New Perspectives on Diagnosis, Prognosis, and Therapy of Malignant Pheochromocytoma/Paraganglioma
Gabriele Parenti et al.
JOURNAL OF ONCOLOGY (2012)
Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
Nelly Burnichon et al.
HUMAN MOLECULAR GENETICS (2011)
dbNSFP: A Lightweight Database of Human Nonsynonymous SNPs and Their Functional Predictions
Xiaoming Liu et al.
HUMAN MUTATION (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Altered Telomeres in Tumors with ATRX and DAXX Mutations
Christopher M. Heaphy et al.
SCIENCE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Fast and accurate long-read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2010)
Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions
Aaron D. Goldberg et al.
CELL (2010)
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3
Pascal Drane et al.
GENES & DEVELOPMENT (2010)
Detection of nonneutral substitution rates on mammalian phylogenies
Katherine S. Pollard et al.
GENOME RESEARCH (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
MutationTaster evaluates disease-causing potential of sequence alterations
Jana Marie Schwarz et al.
NATURE METHODS (2010)
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
Peter W. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes
B. Pasini et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Analysis of selected genes in neuroendocrine tumours: Insulinomas and phaeochromocytomas
R. Hrascan et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Somatic SDHB mutation in an extraadrenal pheochromocytoma
Francien H. van Nederveen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Genetic aberrance of sporadic MEN 2A component tumours: analysis of RET
NH Cho et al.
PATHOLOGY (2005)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
